Introduction

This section includes regimens for primary prophylaxis of Pneumocystis jirovecii pneumonia (PJP) in immunocompromised adults without HIV infection. To assess if primary PJP prophylaxis is indicated, see Assessing the need for antimicrobial prophylaxis in immunocompromised adults without HIV infection.

For primary prophylaxis of PJP in adults with HIV infection, see Pneumocystis jirovecii pneumonia in adults with HIV infection.

For detailed recommendations for PJP prophylaxis in patients with haematological and other malignancies, see the Australian and New Zealand consensus guidelines1.

For treatment and secondary prophylaxis of PJP, see Pneumocystis jirovecii pneumonia (PJP).

1 Cooley L, Dendle C, Wolf J, Teh BW, Chen SC, Boutlis C, et al. Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014. Intern Med J 2014;44(12b):1350-63. [URL]Return